Flourish’s network of 24 sites and 150 investigators conducts studies spanning all phases of clinical trial research Founded in 2010, NMS Capital invests in the lower middle market NMS Capital has ...
NERVIANO, Italy & BOSTON--(BUSINESS WIRE)--Nerviano Medical Sciences S.r.l., a part of NMS Group S.p.A. (NMS Group), focused on the discovery and early development of oncology drugs and the largest ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results